Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 20-Jan-23 4:14 PM View:  | Fate Therapeutics Inc (FATE) | 19-Jan-23 | Option Exercise | 28,461 | $1.37 | $38,991.60 | 10% 282.77K to 311.23K | |
| 13-Jan-23 6:20 PM View: | Fate Therapeutics Inc (FATE) | 13-Jan-23 | Purchase | 36,631 | $5.43 | $198,906.00 | 15% 246.14K to 282.77K | |
| 13-Jan-23 6:20 PM View: | Fate Therapeutics Inc (FATE) | 11-Jan-23 | Private Purchase | 88,048 | $5.67 | $499,232.00 | 56% 158.09K to 246.14K | |
| 13-Jun-22 4:42 PM View: | Fate Therapeutics Inc (FATE) | 09-Jun-22 | Grant | 8,650 | -- | -- | 5% 158.09K to 166.74K | |
| 06-Jun-22 4:49 PM View: | Fate Therapeutics Inc (FATE) | 03-Jun-22 | Sale | 1,364 | $22.79 | $31,085.60 | (< 1%) 159.46K to 158.09K | |
| 11-Mar-22 4:58 PM View: | Fate Therapeutics Inc (FATE) | 10-Mar-22 | Option Exercise | 31,562 | $1.63 | $51,446.10 | 20% 159.46K to 191.02K | |
| 11-Mar-22 4:58 PM View: | Fate Therapeutics Inc (FATE) | 10-Mar-22 | Planned Option Sale | 31,562 | $35.02 | $1,105,200.00 | (17%) 191.02K to 159.46K | |
| 04-Jun-21 5:24 PM View: | Fate Therapeutics Inc (FATE) | 02-Jun-21 | Grant | 2,681 | -- | -- | 2% 156.77K to 159.46K | |
| 26-Dec-18 4:15 PM View: | Atyr Pharma Inc (ATYR) | 21-Dec-18 | Market Purchase | 195,000 | $0.42 | $82,602.00 | 46% 420.38K to 615.38K | (29%) |
| 26-Dec-18 4:15 PM View: | Atyr Pharma Inc (ATYR) | 20-Dec-18 | Market Purchase | 50,000 | $0.41 | $20,645.00 | 13% 370.38K to 420.38K | (28%) |
| 05-Sep-17 7:41 PM View: | Atyr Pharma Inc (ATYR) | 31-Aug-17 | Private Purchase | 37,736 | $2.65 | $100,000.00 | 11% 330.15K to 367.88K | |
| 26-Apr-17 5:02 PM View: | Atyr Pharma Inc (ATYR) | 24-Apr-17 | Market Purchase (Planned) | 124 | $3.00 | $372.00 | < 1% 327.52K to 327.65K | (90%) |
| 20-Apr-17 7:04 PM View: | Atyr Pharma Inc (ATYR) | 20-Apr-17 | Market Purchase (Planned) | 1,552 | $3.00 | $4,656.00 | < 1% 325.97K to 327.52K | (90%) |
| 20-Apr-17 7:04 PM View: | Atyr Pharma Inc (ATYR) | 18-Apr-17 | Market Purchase (Planned) | 1,000 | $3.00 | $3,000.00 | < 1% 324.97K to 325.97K | (90%) |
| 21-Dec-16 11:54 AM View: | Atyr Pharma Inc (ATYR) | 19-Dec-16 | Market Purchase | 69,000 | $2.20 | $151,662.00 | 27% 255.97K to 324.97K | (86%) |
| 06-Apr-16 7:19 PM View: | Atyr Pharma Inc (ATYR) | 05-Apr-16 | Market Purchase | 2,500 | $3.55 | $8,875.00 | 1% 245.97K to 248.47K | (92%) |
| 07-Apr-16 3:25 PM View: | Atyr Pharma Inc (ATYR) | 05-Apr-16 | Market Purchase | 2,500 | $3.52 | $8,800.00 | 1% 248.47K to 250.97K | (92%) |
| 14-May-15 9:29 PM View: | Atyr Pharma Inc (ATYR) | 12-May-15 | Conversion | 24,055 | -- | -- | 11% 221.92K to 245.97K | |
| 07-Oct-13 1:59 PM View: | Fate Therapeutics Inc (FATE) | 04-Oct-13 | Purchase | 16,667 | $6.00 | $100,002.00 | 12% 140.11K to 156.77K |